Vinorelbine + doxorubicin vs doxorubicin: QOL no different in breast cancer

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1250, 2000-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vinorelbine + doxorubicin divided schedule beneficial in breast cancer

Inpharma, Vol. 1, Iss. 1282, 2001-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Doxorubicin + docetaxel vs standard chemo in breast cancer

Inpharma, Vol. 1, Iss. 1512, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Liposomal doxorubicin vs epirubicin in breast cancer

Inpharma, Vol. 1, Iss. 1462, 2004-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Liposomal doxorubicin in combination with vinorelbine shows promise as a treatment for patients with pretreated advanced breast cancer

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Vinorelbine/epirubicin vs AC in operable breast cancer

Inpharma, Vol. 1, Iss. 1515, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite